Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury

Clinical trial NCT00123591 · COMPLETED

Trial details

NCT number: NCT00123591
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Trauma

Start date: 2005-01-01
Primary completion: 2006-05-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.